• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 309/08 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 309/08

Total number of patents in this class: 224

10-year publication summary

16
17
25
13
18
15
25
10
11
2
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Corsair Pharma, Inc.
37
13
Bristol-myers Squibb Company
4812
11
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin
176
7
The University of Queensland
663
7
The General Hospital Corporation
4824
6
The Broad Institute, Inc.
1932
6
Enanta Pharmaceuticals, Inc.
431
6
Global Blood Therapeutics, Inc.
177
6
Massachusetts Institute of Technology
10201
5
Theravance Biopharma R&D IP, LLC
425
5
Xwpharma Ltd.
64
5
Abbvie Inc.
1842
4
Takeda Pharmaceutical Company Limited
2721
4
Cytokinetics, Inc.
256
4
Dongjin Semichem Co., Ltd.
492
4
Temple University of the Commonwealth System of Higher Education
636
4
Praeventix, LLC
17
4
Orsobio, Inc.
17
4
BASF SE
21129
3
Modernatx, Inc.
1280
3
Other owners 113